Metrion Biosciences has appointed a Head of European Business Development to support the next phase of the company’s ion channel drug discovery services.
The company has appointed Dr Benedetta Montagnini as Head of European Business Development in a move which follows the recent creation of a Client Services as Metrion expands its international drug discovery capabilities.
Dr Montagnini will provide local support to Metrion’s existing client base across Europe and Israel, along with leading the development of new business opportunities in the ion channel field. With over 20 years’ experience working within the drug discovery services environment, Dr Montagnini was previously Business Development Manager at Eurofins Discovery and DiscoveRx and prior to that Account Manager for the Industrial BioProcessing Division at Invitrogen.
Dr Benedetta Montagnini, Head of European Business Development at Metrion Biosciences, commented: “Metrion’s continued growth substantiates its position as a leading provider of drug discovery research services for ion channel targets across a broad range of therapeutic areas. This reputation attracted me to the Company, and I am delighted to be joining the team at this point in its expansion. I look forward to working with both existing and new clients and supporting the community across Europe. I have a great respect for Metrion’s strong scientific focus for ion channel drug discovery and vision for the future development of its services”
Nick Foster, Chief Commercial Officer of Metrion Biosciences, said: “It is a pleasure to welcome Benedetta to the Metrion team. Engaging with and supporting our clients, locally and internationally, is Metrion’s top priority and this exciting development enables us to enhance our ability to provide local support in Europe. Benedetta’s appointment and the continuing expansion of our team of scientists, celebrates the Company’s success and gives us a strong footing for our future growth in these regions.”